TerminatedPhase 2NCT01334710

A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer

Studying Adult hepatocellular carcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Emory University
Principal Investigator
Bassel El-Rayes, MD, M.D
Emory University Winship Cancer Institute
Intervention
Sorafenib and OSI-906(drug)
Enrollment
3 enrolled
Eligibility
18 years · All sexes
Timeline
2011 – 2011

Study locations (3)

Collaborators

OSI Pharmaceuticals

Published results

No published results indexed yet.Verified against PubMed's DataBankList cross-reference. This means either: (a) the trial has not yet published, (b) results were published without registering the NCT cross-reference, or (c) our index is still catching up. Patients can check ClinicalTrials.gov directly or search PubMed for the PI's recent work.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01334710 on ClinicalTrials.gov

Other trials for Adult hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Adult hepatocellular carcinoma →

← Back to all trials